✕ CLOSE Online Special City News Entrepreneurship Environment Factcheck Everything Woman Home Front Islamic Forum Life Xtra Property Travel & Leisure Viewpoint Vox Pop Women In Business Art and Ideas Bookshelf Labour Law Letters
Click Here To Listen To Trust Radio Live

COVID-19: Run-away patient intercepted in Enugu

The Enugu State Rapid Response Task Force on COVID-19 and security agencies have intercepted a run-away COVID-19 patient from the Delta State Isolation and Treatment…

The Enugu State Rapid Response Task Force on COVID-19 and security agencies have intercepted a run-away COVID-19 patient from the Delta State Isolation and Treatment Centre.

Prof. Ikechukwu Obi, the state Commissioner for Health, made this known in a statement on Tuesday in Enugu.

Obi said that the run-away COVID-19 patient was intercepted in the state on Monday by the security agencies, in active collaboration with the Delta COVID-19 task force.

He said the arrest followed the directive by the Enugu State Governor, Ifeanyi Ugwuanyi, that the absconded patient be located and returned to the Delta isolation centre.

The commissioner said that contact tracing of those who had contacts with the run-away patient and the decontamination of the places the patient had been to while in Enugu, had begun.

“The ministry, therefore, reminds the good people of the state that in times like these, we owe a responsibility to each other to inform relevant authorities when we develop symptoms or know someone who may have symptoms or history of cross boundary travel into the state.

“The numbers to call are 08182555550, 09022333833, or the NCDC number 080097000010,’’ he said.

The News Agency of Nigeria (NAN) reports that Enugu state has recorded a total of eight COVID-19 cases.

The state at present have six active cases receiving treatment while two others had been successfully treated and discharged.

VERIFIED: It is now possible to live in Nigeria and earn salary in US Dollars with premium domains, you can earn as much as $12,000 (₦18 Million).
Click here to start.